These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 7507118)

  • 1. Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.
    Magiakou MA; Mastorakos G; Gomez MT; Rose SR; Chrousos GP
    J Clin Endocrinol Metab; 1994 Jan; 78(1):131-7. PubMed ID: 7507118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children.
    Smith WJ; Nam TJ; Underwood LE; Busby WH; Celnicker A; Clemmons DR
    J Clin Endocrinol Metab; 1993 Nov; 77(5):1294-9. PubMed ID: 7521346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apparently complete restoration of normal daily adrenocorticotropin, cortisol, growth hormone, and prolactin secretory dynamics in adults with Cushing's disease after clinically successful transsphenoidal adenomectomy.
    Veldman RG; Frölich M; Pincus SM; Veldhuis JD; Roelfsema F
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4039-46. PubMed ID: 11095430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonparallel changes of growth hormone (GH) and insulin-like growth factor-I, insulin-like growth factor binding protein-3, and GH-binding protein, after craniospinal irradiation and chemotherapy.
    Nivot S; Benelli C; Clot JP; Saucet C; Adan L; Souberbielle JC; Zucker JM; Rappaport R; Brauner R
    J Clin Endocrinol Metab; 1994 Mar; 78(3):597-601. PubMed ID: 7510304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone status following treatment for Cushing's syndrome.
    Hughes NR; Lissett CA; Shalet SM
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):61-6. PubMed ID: 10468966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to increase insulin-like growth factor-I synthesis is involved in the mechanisms of growth retardation of children with inherited liver disorders.
    Maghnie M; Barreca A; Ventura M; Tinelli C; Ponzani P; De Giacomo C; Maggiore G; Severi F
    Clin Endocrinol (Oxf); 1998 Jun; 48(6):747-55. PubMed ID: 9713564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome.
    Bang P; Degerblad M; Thorén M; Schwander J; Blum W; Hall K
    Acta Endocrinol (Copenh); 1993 May; 128(5):397-404. PubMed ID: 7686320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
    Grinspoon S; Clemmons D; Swearingen B; Klibanski A
    J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis of severe growth hormone deficiency in elderly patients with hypothalamic-pituitary disease.
    Toogood AA; Jones J; O'Neill PA; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 1998 May; 48(5):569-76. PubMed ID: 9666868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of arginine and pyridostigmine on the GHRH-induced GH rise in obesity and Cushing's syndrome.
    Procopio M; Invitti C; Maccario M; Grottoli S; Cavagnini F; Camanni F; Ghigo E
    Int J Obes Relat Metab Disord; 1995 Feb; 19(2):108-12. PubMed ID: 7735336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation.
    Argente J; Caballo N; Barrios V; Muñoz MT; Pozo J; Chowen JA; Morandé G; Hernández M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2084-92. PubMed ID: 9215276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
    Mukherjee A; Murray RD; Teasdale GM; Shalet SM
    Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four-hour plasma growth hormone (GH) profiles, urinary GH excretion, and plasma insulin-like growth factor-I and -II levels in prepubertal children with chronic renal insufficiency and severe growth retardation.
    Hokken-Koelega AC; Hackeng WH; Stijnen T; Wit JM; de Muinck Keizer-Schrama SM; Drop SL
    J Clin Endocrinol Metab; 1990 Sep; 71(3):688-95. PubMed ID: 2394775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in insulin-like growth factor-I (IGF-I), IGF-binding protein-3, growth hormone (GH)-binding protein, erythrocyte IGF-I receptors, and growth rate during GH treatment.
    Mandel S; Moreland E; Nichols V; Hanna C; Lafranchi S
    J Clin Endocrinol Metab; 1995 Jan; 80(1):190-4. PubMed ID: 7530256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children--a clinical research center study.
    Nunez SB; Municchi G; Barnes KM; Rose SR
    J Clin Endocrinol Metab; 1996 May; 81(5):1927-32. PubMed ID: 8626859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
    Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
    Rasmussen MH; Hvidberg A; Juul A; Main KM; Gotfredsen A; Skakkebaek NE; Hilsted J; Skakkebae NE
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1407-15. PubMed ID: 7536210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant GH deficiency after long-term cure by surgery in adult patients with Cushing's disease.
    Pecori Giraldi F; Andrioli M; De Marinis L; Bianchi A; Giampietro A; De Martin M; Sacco E; Scacchi M; Pontecorvi A; Cavagnini F
    Eur J Endocrinol; 2007 Feb; 156(2):233-9. PubMed ID: 17287413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.